Asad Ali

Asad Ali

Auto-generated profile, based on publicly available information

Asad Ali

Institute of Microbiology and Molecular Genetics , University of the Punjab , Lahore , Punjab , Pakistan , pu.edu.pk

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Journal of Infection and Public Health
Verified
Journal Article
Open access
AKAmir Afzal Khan
Amir Afzal Khan
AAAsad Ali
Asad Ali
DTDr. Nagendran Tharmalingam
Dr. Nagendran Tharmalingam
EMEleftherios Mylonakis
Eleftherios Mylonakis
RZRabaab Zahra
Rabaab Zahra
Staphylococcus aureus (S. aureus) is one of the leading causes of community and hospital acquired infections globally. The objective of the study was to assess the prevalence, study the carriage of antibiotic resistance genes and evaluate the molecular typing of S. aureus isolates from a tertiary care hospital in Islamabad. A total of 1528 staphylococci isolates were included in this study. Standard microbiological procedures were applied to identify S. aureus. Antimicrobial susceptability was evaluated using the disk diffusion method and Minimum Inhibitory Concentrations (MICs) were determined using microbroth dilution method following Clinical and Laboratory Standards Institute (CLSI) guidelines. Multiplex PCR was used to detect antibiotic resistance genes, and molecular typing was performed using agr, SCCmec, spa, and Multi-Locus Sequence Typing (MLST) and clonal relatedness by Pulse Field Gel Electrophoresis (PFGE) methods. Overall 65% were MRSA and 35% were methicillin sensitive Staphylococcus aureus (MSSA). Among MRSA isolates, 83% were multi-drug resistant and mecA was found in 54% isolates, mecC was in 3% while 1 MRSA carried both mecA and mecC genes. agrI (22%) was most prevalent group in MRSA, while agrIII (16%) was observed in MSSA. SCCmec types I, II, III, IV, and VI were detected, with high prevalence of type III while type V was absent. The prevelant spa type in MRSA was t657 with SCCmecIII elelments while in MSSA it was t021. One NEW spa type identified in MSSA isolates. In a subset of isolates, ST772 with SCCmecIV, ST1 carrying PVL marker, and ST1535 was reported first time from Pakistan. The study presents a comprehensive analysis of prevalent S. aureus types and their antibiotic resistance profiles. It also reports for the first time SCCmec type VI and clinical MRSA isolates with mecC alone and in combination with mecA from Islamabad, Pakistan. This calls for further detailed investigations in other hospital settings in the region.

1 January 2022 in Sage Open Medicine
Verified
Journal Article
Open access
MTMehlayl Tariq
Mehlayl Tariq
ASAbu Bakar Shoukat
Abu Bakar Shoukat
SASedrah Akbar
Sedrah Akbar
SHSamaia Hameed
Samaia Hameed
MNMuniba Zainab Naqvi
Muniba Zainab Naqvi
SAShahid Aziz
Shahid Aziz
Viral hepatitis is a major public health concern. It is associated with life threatening conditions including liver cirrhosis and hepatocellular carcinoma. Hepatitis C virus infects around 71 million people annually, resultantly 700,000 deaths worldwide. Extrahepatic associated chronic hepatitis C virus accounts for one fourth of total healthcare load. This review included a total of 150 studies that revealed almost 19 million people are infected with hepatitis C virus and 240,000 new cases are being reported each year. This trend is continually rising in developing countries like Pakistan where intravenous drug abuse, street barbers, unsafe blood transfusions, use of unsterilized surgical instruments and recycled syringes plays a major role in virus transmission. Almost 123–180 million people are found to be hepatitis C virus infected or carrier that accounts for 2%–3% of world’s population. The general symptoms of hepatitis C virus infection include fatigue, jaundice, dark urine, anorexia, fever malaise, nausea and constipation varying on severity and chronicity of infection. More than 90% of hepatitis C virus infected patients are treated with direct-acting antiviral agents that prevent progression of liver disease, decreasing the elevation of hepatocellular carcinoma. Standardizing the healthcare techniques, minimizing the street practices, and screening for viral hepatitis on mass levels for early diagnosis and prompt treatment may help in decreasing the burden on already fragmented healthcare system. However, more advanced studies on larger populations focusing on mode of transmission and treatment protocols are warranted to understand and minimize the overall infection and death stigma among masses.

22 March 2021 in Pilot and Feasibility Studies
Verified
Journal Article
Open access
PDF file
CAChristina Antza
Christina Antza
RORyan Ottridge
Ryan Ottridge
SPSmitaa Patel
Smitaa Patel
GSGemma Slinn
Gemma Slinn
STSarah Tearne
Sarah Tearne
ATAbd Tahrani
Abd Tahrani
Background: Obstructive sleep apnoea (OSA) is very common in patients with type 2 diabetes (T2D). We and others have shown that OSA was associated with diabetes-related microvascular complications in patients with T2D in cross-sectional and longitudinal studies and that compliance with continuous positive airway pressure (CPAP) reduced the progression of microvascular complications. Hence, we hypothesised that adequate CPAP reduces the development of microvascular complication in patients with T2D. Methods: SLEEP T2D is a cohort study with embedded feasibility, open-label, parallel-arm, randomised control trial (RCT) over 2 years. The primary aim is the feasibility of conducting a definitive RCT assessing the impact of CPAP on chronic kidney disease and other microvascular complications in patients with T2D. The main parameters are to assess willingness of participants to be randomised, follow-up rates, CPAP adherence/compliance, to optimise the choice of outcome measures for a substantive trial, and to identify the parameters for sample size calculations. The secondary aims of the study are related to the impact of CPAP, sleep-related disorders, and sleep chronotype on a variety of diabetes-related end points. The study participants were recruited from the T2D services in multiple NHS trusts across England. The main exclusion criteria for the cohort study are as follows: T1D, eGFR < 15 mL/min/1.73 m2, known OSA, active malignancy or chronic kidney disease from reasons other than diabetes, pregnancy, professional drivers, and a history of falling asleep whilst driving within last 2 years. The main exclusion criteria from the RCT were as follows: Apnoea-Hypopnoea Index < 10 and Epworth Sleepiness Score ≥ 11. Study participants were extensively phenotyped clinically and biochemically. The OSA diagnosis was based on multichannel portable device (ApneaLink AirTM, Resmed). Discussion: The feasibility RCT will help us design the future RCT to assess the impact of CPAP on diabetes-related microvascular complications. The cohort study will generate preliminary data regarding the impact of sleep quality, duration, and chronotype on diabetes-related outcomes which could lead to further mechanistic and interventional studies. Trial registration: ISRCTN, ISRCTN12361838. Registered 04 April 2018, Protocol version: v5.0 02.12.19.

17 June 2024 in Future Microbiology
Verified
Journal Article
Closed access
NANoor Ul Ain
Noor Ul Ain
AHAbdul Hannan
Abdul Hannan
NINamrah Imran
Namrah Imran
AAAsad Ali
Asad Ali
Farhan RasheedFarhan Rasheed
Farhan Rasheed
SRSaba Riaz
Saba Riaz
Aim: The study determines rates of carbapenem resistance (CR) and frequency of blaNDM in multidrug-resistance (MDR) or extensive drug resistance (XDR), and evaluates the potential of phenotypic tests for detecting NDM production. Materials & methods: Singleplex PCR was used to detect blaNDM. Phenotypic tests, including combination disc test (CDST) and modified Hodge test (MHT), were evaluated for NDM production. Results: Among 338 CR isolates, 47.63% were MDR, whereas 52.36% were XDR with 53.25% carrying blaNDM. MHT was found to be discriminative for detecting NDM production, whereas no significant association was observed for CDST. Conclusion: The high incidence of CR and MDR and XDR isolates possessing blaNDM presents an impending threat in therapeutics. Limitations of phenotypic tests suggest better testing, including molecular detection of the enzyme.

1 January 2026 in International Journal of Microbiology
Verified
Journal Article
Open access
PDF file
AAAsad Ali
Asad Ali
SJSaman Jabbar
Saman Jabbar
SAShahid Aziz
Shahid Aziz
SRSaba Riaz
Saba Riaz
Background: Methicillin‐resistant Staphylococcus aureus (MRSA) is one of the leading causes of hospital and community‐acquired infections, with the increasing threat of antimicrobial resistance worldwide. Staphylococcal Cassette Chromosome mec (SCC mec ) typing is one of the molecular techniques to predict the genetic background of MRSA strains and predict the level of antibiotic resistance. This study aimed to find out and compare the predominant SCC mec types in the hospital and community settings along with antibiotic resistance burden. Methods: A total of 295 MRSA isolates were recovered from the hospital and community settings in Lahore, Pakistan. The growth characteristics of the isolates were initially determined using Mannitol salt agar (MSA). Isolates were then subjected to further biochemical confirmation by catalase, DNase and tube coagulase tests according to standard operating procedure used in Pakistan. MRSA screening was performed using Cefoxitin 30 μ g disc. Antibiotic resistance patterns were determined against commonly used antibiotics, and the results were interpreted according to Clinical and Laboratory Standards Institute (CLSI) guidelines. Molecular detection of MRSA was done by mecA gene, and a multiplex PCR was used to determine the prevalent SCC mec types (I‐VI). Results: A total of 145 (49.15%) MRSA isolates were identified. SCC mec type III was predominant (39.31%, n = 57), while no type V was detected. Antibiotic resistance profiles revealed the highest resistance towards ciprofloxacin (78.62%), while high susceptibility rates were recorded for ceftaroline (95.17%), quinupristin/dalfopristin (93.79%), and linezolid (91.03%). Ciprofloxacin resistance was significantly associated with SCC mec type III. Type I SCC mec was associated considerably with samples originating from clinical sources. Conclusions: Prevalence of MRSA and the types of SCC mec are on the rise. Because of the high prevalence of multiresistant type III cassettes, antibiotic resistance is also increasing. The high occurrence of community‐specific SCC mec in hospital settings suggests implementing infection control practices to prevent severe MRSA infection and the rise in antibiotic resistance.